BLENREP (BELANTAMAB MAFODOTIN-BLMF) — FDA Approval BLA761440 (GLAXOSMITHKLINE LLC)
BLENREP (BELANTAMAB MAFODOTIN-BLMF) — FDA Approval BLA761440 (GLAXOSMITHKLINE LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BLENREP; Active ingredients: BELANTAMAB MAFODOTIN-BLMF; Application number: BLA761440.
| Brand name | BLENREP |
|---|---|
| Active ingredients | BELANTAMAB MAFODOTIN-BLMF |
| Application number | BLA761440 |
| Sponsor | GLAXOSMITHKLINE LLC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20251023 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →